Global VRE and MRSA Antibiotic Market Outlook 2021

Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) are specific, antibiotic-resistant bacteria that spread by contact and can cause serious infections. MRSA can be spread by touching articles that have been contaminated by the skin of an infected or colonized person, such as towels, sheets, and wound dressings; VRE can be transmitted by touching articles soiled by an infected person’s feces. Both of these bacteria survive well on hands and for weeks on inanimate objects. Colonization occurs when bacteria are present on or in the body (i.e., nose, skin, rectum, moist areas of the body and the newborn’s umbilicus) without causing illness.
An antibiotic is a type of antimicrobial substance active against bacteria. It is the most important type of antibacterial agent for fighting bacterial infections, and antibiotic medications are widely used in the treatment and prevention of such infections. They may either kill or inhibit the growth of bacteria.
The market for is VRE and MRSA Antibiotic market fragmented with players such as Pfizer, Lilly, Sanofi Aventis, Merck, Fresenius Kabi, Xellia Pharmaceuticals (Novo Holdings), Zhejiang Medicine, Zhejiang Hisun Pharmaceutical, North China Pharmaceutical. Among the companies, pfizer contributed 16% of the market, which is the biggest in 2019.
Category, included in this market are Teicoplanin, Vancomycin, Linezolid, Daptomycin, Others. The Linezolid contributed most in the revenue of the VRE and MRSA Antibiotic，which is 38% of the market.
The application for VRE and MRSA Antibiotic market is segment with application such as hospitals, clinics and others, in 2020, the sales in the hospitals is the biggest, occupies almost 2/3 of the market.
As for the regional market share, the Americas is expected to hold the largest share of the global MRSA drugs market.

The global VRE and MRSA Antibiotic market size is projected to reach US$ 5128 million by 2026, from US$ 3886.2 million in 2020, at a CAGR of 4.7% during 2021-2026.
This report focuses on VRE and MRSA Antibiotic volume and value at the global level, regional level and company level. From a global perspective, this report represents overall VRE and MRSA Antibiotic market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, etc.

Global VRE and MRSA Antibiotic Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the VRE and MRSA Antibiotic market is segmented into
Vancomycin
Teicoplanin
Linezolid
Daptomycin
Others

Segment by Application
Hospitals
Clinics
Others

Global VRE and MRSA Antibiotic Market: Regional Analysis
The VRE and MRSA Antibiotic market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the VRE and MRSA Antibiotic market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Global VRE and MRSA Antibiotic Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global VRE and MRSA Antibiotic market include:
Pfizer
Lilly
Sanofi Aventis
Merck
Fresenius Kabi
Xellia Pharmaceuticals (Novo Holdings)
Zhejiang Medicine
Zhejiang Hisun Pharmaceutical
North China Pharmaceutical
Korea United Pharm

Frequently Asked Questions